Anteris Technologies Global Corp: 5%+ holders

As of November 6, 2026, 5 holders' latest Schedule 13D or 13G filings report owning 5% or more of Anteris Technologies Global Corp. The largest reported stake is Medtronic plc's, at 16.2%. 18 filings are on record since August 13, 2025 (Schedule 13D, January 29, 2026).

Medtronic plc also filed stake reports on 2 other companies ↓

Sell to companies like Anteris Technologies Global Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Your website Find my buyers

Opens in a new tab. No signup.

Key facts

• Filing 2026-11-05 · Reporting person: Fmr LLC · Sole voting: 8,483,404 · Shared voting: 0 · Sole dispositive: 8,484,333 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-11-05
• Filing 2026-09-03 · Reporting person: L1 Capital Pty Ltd · Sole voting: 11,496,345 · Shared voting: 0 · Sole dispositive: 11,496,345 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-09-03
• Filing 2026-08-14 · Reporting person: Nantahala Capital Management, LLC · Sole voting: 0 · Shared voting: 3,995,579 · Sole dispositive: 0 · Shared dispositive: 3,995,579 · SCHEDULE 13G/A, 2026-08-14
• Filed 2026-08-07 · Holder: L1 Capital Pty Ltd · Percent: 13.46% · SCHEDULE 13G/A
• Filed 2026-08-06 · Holder: Fmr LLC · Percent: 7.5% · SCHEDULE 13G

Anteris Technologies Global Corp has 18 Schedule 13D or 13G filings on record since 2025-08-13. 5 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Holders

Swipe the table sideways to see every column.

Holding shares or following this stake? See who's behind Anteris Technologies Global Corp and the warning signs.

See Anteris Technologies Global Corp's free Snapshot Watch Anteris Technologies Global Corp: email me the next time it files something

Free to see. No signup.

Keep reading

More on Anteris Technologies Global Corp and the records around it.

Anteris Technologies Global Corp elsewhere on the record

• Leadership changes Sep 2026
• IPO filing Nov 2025
• Form D filing Nov 2025
• Who owns it

Companies that share a holder

• Medtronic plc also filed stake reports on 2 other companies: Orchestra BioMed Holdings, Inc. (Feb 2026)
• L1 Capital Pty Ltd also filed stake reports on 4 other companies: Eldorado Gold Corp (May 2026)
• Sio Capital Management, LLC also filed stake reports on 9 other companies: Enveric Biosciences, Inc. (Nov 2026), Adagio Medical Holdings, Inc. (Jul 2026), PMV Pharmaceuticals, Inc. (Jul 2026)

Want the whole picture on Anteris Technologies Global Corp?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Anteris Technologies Global Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Anteris Technologies Global Corp covers

1. The Short Answer

2. Which Company This Is

3. What They Do, And How The Money Works

4. Who Runs It, And How To Reach Them

5. The Money: Funding, Valuation, Runway

6. Who Pays Them, And Who They Are Up Against

7. Warning Bells

8. Sources

   26 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

Order Full ReportSee a sample report

A real finished report, first screen. Opens in a new tab.

Voting and dispositive power, as filed

Swipe the table sideways to see every column.

The latest filing identifies Anteris Technologies Global Corp by CUSIP 03675P102 and gives its principal executive office as 860 BLUE GENTIAN ROAD, SUITE 340, EAGAN, MN 55121 (SCHEDULE 13G/A, 2026-11-05).

Purpose of Transaction (Item 4)

Medtronic plc

The information set forth in Item 3 of this Schedule 13D is hereby incorporated by reference in its entirety into this Item 4. In connection with the Purchase Agreement, Anteris and Covidien entered into a Registration Rights Agreement (the "Registration Rights Agreement"), dated as of January 22, 2026. Pursuant to the Registration Rights Agreement, Anteris shall prepare and file with the Securities and Exchange Commission a registration statement covering the resale of all of the Shares not already covered by an existing and effective registration statement as soon as reasonably practicable and in any event no later than the 18th-month anniversary of the Closing Date (as defined in the Purchase Agreement) and indemnify, defend and hold harmless each holder of Shares in connection therewith. Anteris and Covidien also entered into an Investor Rights Agreement dated as of January 22, 2026 in connection with the Purchase Agreement (the "Investor Rights Agreement"). Pursuant to the Investor Rights Agreement, Covidien will have a participation right with respect to the issuance of certain of Anteris's securities. Further pursuant to the Investor Rights Agreement, Covidien shall have the right to designate one non-voting observer to the Anteris Board of Directors. The Investor Rights Agreement also contains transfer restrictions through May 22, 2027, an agreement to discuss potential collaborations, a customary standstill provision, a voting agreement, and a requirement upon …The first part of Item 4 of the SCHEDULE 13D filed 2026-01-29; the filing has the rest

Timeline

Swipe the table sideways to see every column.

Questions about who owns Anteris Technologies Global Corp

Who owns Anteris Technologies Global Corp?

On this page, 5 holders' latest ownership filings report 5% or more of Anteris Technologies Global Corp: Medtronic plc (16.2%, Schedule 13D, filed 2026-01-29), L1 Capital Pty Ltd (11.64%, Schedule 13G/A, filed 2026-09-03), Fmr LLC (8.7%, Schedule 13G/A, filed 2026-11-05), Sio Capital Management, LLC (5.54%, Schedule 13G/A, filed 2026-05-04) and BlackRock, Inc. (5.01%, Schedule 13G, filed 2026-04-27).

Who are the largest shareholders of Anteris Technologies Global Corp?

By the share each holder's latest filing reports, the largest holders of Anteris Technologies Global Corp on this page are Medtronic plc (16.2%), L1 Capital Pty Ltd (11.64%) and Fmr LLC (8.7%).

When did Medtronic plc buy into Anteris Technologies Global Corp?

The filings give report dates, not purchase dates. The earliest filing from Medtronic plc on this page is the Schedule 13D, filed 2026-01-29, reporting 16.2%.

Is this an audit or a full list?

Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 18 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.

Also on the record for Anteris Technologies Global Corp

Swipe the table sideways to see every column.

Tools for this story

Each opens in a new tab, filled in for Anteris Technologies Global Corp. With no account yet, you sign up free and land on the result.

• Get an alert when Anteris Technologies Global Corp is mentioned again
• Find former Anteris Technologies Global Corp employees to interview
• Verify a claim or statistic

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

All recent stakesThat week's stakes